MJA
MJA InSight
MJA Careers
Perspectives

Disease mongering and low testosterone in men: the tale of two regulatory failures

Agnes I Vitry and Barbara Mintzes
Med J Aust 2012; 196 (10): 619-621.
doi:
10.5694/mja11.11299

Disease-awareness campaigns on low testosterone and ageing highlight the need for changes to regulations

Agnes I Vitry, PharmD, PhD, Senior Research Fellow1
Barbara Mintzes, PhD, Assistant Professor2
1 Quality Use of Medicines and Pharmacy Practice Research Centre, Sansom Institute for Health Research, University of South Australia, Adelaide, SA.
2 Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Article References: 
Reference Text: 
Mackenzie FJ, Jordens CF, Ankeny RA, et al. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia. Intern Med J 2007; 37: 224-228.
Reference Order: 
1
PubMed ID: 
17388861
Reference Text: 
Mintzes B. Disease mongering in drug promotion: do governments have a regulatory role? PLoS Med 2006; 3: e198.
Reference Order: 
2
PubMed ID: 
16597181
Reference Text: 
‘t Jong GW, Stricker BH, Sturkenboom MC. Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. BMJ 2004; 328: 931.
Reference Order: 
3
PubMed ID: 
14988148
Reference Text: 
Brody H, Light DW. The inverse benefit law: how drug marketing undermines patient safety and public health. Am J Public Health 2011; 101: 399-404.
Reference Order: 
4
PubMed ID: 
21233426
Reference Text: 
Abbott Canada. Not feeling like the man you used to be [advertising campaign]? http://www.lowt.ca/index.php (accessed Oct 2011).
Reference Order: 
5
Reference Text: 
Testosterone for “late-onset hypogonadism” in men. Drug Ther Bull 2010; 48: 69-72.
Reference Order: 
6
PubMed ID: 
20530029
Reference Text: 
Handelsman DJ. Testosterone and male ageing: spinning the wheels. Med J Aust 2010; 193: 379-380.
Reference Order: 
7
Reference Text: 
Fernández-Balsells MM, Murad MH, Lane M, et al. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010; 95: 2560-2575.
Reference Order: 
8
PubMed ID: 
20525906
Reference Text: 
Haddad RM, Kennedy CC, Caples SM, et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82: 29-39.
Reference Order: 
9
PubMed ID: 
17285783
Reference Text: 
Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109-122.
Reference Order: 
10
PubMed ID: 
20592293
Reference Text: 
Medicines Australia. Code of Conduct. Edition 15. http://medicinesaustralia .com.au/files/2010/01/Code-of-Conduct-Edition-15.pdf (accessed May 2012).
Reference Order: 
11
Reference Text: 
Medicines Australia Code of Conduct. Annual report 2011. http://medicinesaustralia.com.au/files/2010/01/20110829-PUB-CoC-AnnualReport-2010_2011.pdf (accessed May 2012).
Reference Order: 
12
Reference Text: 
Medicare Australia. PBS statistics. Canberra: Australian Government Department of Human Services, 2012. http://www.medicareaustralia.gov.au/provider/pbs/stats.jsp (accessed Jan 2012).
Reference Order: 
13
Reference Text: 
Hall DV, Jones SC, Iverson DC. Content analysis of disease awareness advertisements in popular Australian women’s magazines. Med J Aust 2009; 191: 625-629.
Reference Order: 
14
Reference Text: 
HAI Europe, ISDB, AIM, BEUC, Medicines in Europe Forum. Relevant health information for empowered citizens. Joint Declaration, 2006. http://english.prescrire.org/Docu/Archive/docus/declarationInfoPatientEN0610.pdf (accessed Oct 2011).
Reference Order: 
15
Reference Text: 
World Health Organization. Ethical criteria for medicinal drug promotion. http://whqlibdoc.who.int/publications/1988/924154239X_eng.pdf (accessed May 2012).
Reference Order: 
16

The full contents of this page are only available to subscribers.